受伤儿童全血占总输血量比例:一项全国数据库分析
该研究基于美国外科医师学会创伤质量改进项目数据库,纳入456家美国创伤中心、18岁以下、到院4小时内接受任何输血的受伤儿童4323例,其中88%(3786例)仅接受成分输血,12%(537例)接受全血(联合或不联合成分输血)。接受全血者休克比例更高(儿童年龄校正休克指数71% vs 60%),损伤严重度评分中位数更高(26 vs 25,p=0.007)。多因素分析显示,任何全血输注与4小时死亡风险降低42%相关(aOR 0.58,95%CI 0.35-0.97;p=0.038)、与24小时死亡风险降低54%相关(aOR 0.46,95%CI 0.33-0.66;p<0.001);全血占总输血量比例每增加10%,24小时死亡风险降低9%(aOR 0.91,95%CI 0.85-0.97;p=0.006)。年龄小于14岁和接受大量输血(>40 mL/kg)的亚组分析也显示24小时死亡率有统计学显著生存获益。
要点
- 在4323例受伤儿童中,接受任何全血输注与24小时死亡风险降低54%独立相关(aOR 0.46,95%CI 0.33-0.66;p<0.001)。
- 全血占总输血量比例每增加10%,24小时死亡风险降低9%(aOR 0.91,95%CI 0.85-0.97;p=0.006),呈阶梯式生存获益。
- 接受全血者病情更重:儿童年龄校正休克指数提示休克者占71% vs 60%,损伤严重度评分中位数26 vs 25(p=0.007)。
- 年龄小于14岁和接受大量输血(>40 mL/kg)的亚组均显示24小时死亡率有统计学显著生存获益。
- 任何全血输注与4小时死亡风险降低42%相关(aOR 0.58,95%CI 0.35-0.97;p=0.038)。
适用人群与场景
- 美国456家创伤中心收治的18岁以下受伤儿童,且在到院4小时内接受任何血制品输注者。
研究设计与关键结果
- 研究类型:基于美国外科医师学会创伤质量改进项目数据库的回顾性分析,最终分析纳入4323例受伤儿童。
- 分组:88%(3786例)仅接受成分输血,12%(537例)接受全血(联合或不联合成分输血)。
- 基线差异:全血组儿童年龄校正休克指数提示休克者占71% vs 成分输血组60%;损伤严重度评分中位数26(四分位距17-35)vs 25(16-24),p=0.007。
- 主要终点24小时死亡率:任何全血输注aOR 0.46(95%CI 0.33-0.66),p<0.001。
- 次要终点4小时死亡率:任何全血输注aOR 0.58(95%CI 0.35-0.97),p=0.038。
- 剂量效应:全血占总输血量比例每增加10%,24小时死亡风险aOR 0.91(95%CI 0.85-0.97),p=0.006。
- 亚组分析:年龄小于14岁和接受大量输血(>40 mL/kg)者,24小时死亡率均有统计学显著生存获益。
证据类型、等级与局限
- 证据类型:回顾性数据库分析;证据等级:治疗/管理,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在受伤儿童中,使用全血与24小时死亡率降低独立相关,且全血占总复苏量比例越高,生存获益呈阶梯式增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Whole blood (WB) resuscitation is increasingly common in adult trauma centers and some pediatric trauma centers, as studies have noted its safety and potential superiority to component therapy (CT). Previous analyses have evaluated WB as a binary variable (any versus none), and little is known regarding the "dose response" of WB in relation to total transfusion volume (TTV) (WB/TTV ratio).
METHODS: Injured children younger than 18 years who received any blood transfusion within 4 hours of hospital arrival across 456 US trauma centers were included from the American College of Surgeons Trauma Quality Improvement Program database. The primary outcome was 24-hour mortality, and the secondary outcome was 4-hour mortality. Multivariate analysis was used to evaluate associations between WB administration and mortality and WB/TTV ratio and mortality.
RESULTS: Of 4,323 pediatric patients included in final analysis, 88% (3,786) received CT only, and 12% (537) received WB with or without CT. Compared with the CT group, WB recipients were more likely to be in shock, according to pediatric age-adjusted shock index (71% vs. 60%) and had higher median (interquartile range) Injury Severity Score (26 [17-35] vs. 25 [16-24], p = 0.007). Any WB transfusion was associated with 42% decreased odds of mortality at 4 hours (adjusted odds ratio [aOR], 0.58 [95% confidence interval, 0.35-0.97]; p = 0.038) and 54% decreased odds of mortality at 24 hours (aOR, 0.46 [0.33-0.66]; p < 0.001). Each 10% increase in WB/TTV ratio was associated with a 9% decrease in 24-hour mortality (aOR, 0.91 [0.85-0.97]; p = 0.006). Subgroup analyses for age younger than 14 years and receipt of massive transfusion (>40 mL/kg) also showed statistically significant survival benefit for 24-hour mortality.
CONCLUSION: In this retrospective American College of Surgeons Trauma Quality Improvement Program analysis, use of WB was independently associated with reduced 24-hour mortality in children; further, higher proportions of WB used over the total resuscitation (WB/TTV ratio) were associated with a stepwise increase in survival.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Campwala I, Dorken-Gallastegi A, Spinella PC, et al. Whole blood to total transfusion volume ratio in injured children: A national database analysis. J Trauma Acute Care Surg. 2024. PMID: 39269259. doi:10.1097/TA.0000000000004443
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。